Right ventricular outflow tract revalvulation using the Melody Valve: The next frontier

Congenital heart lesions with abnormal right ventricular outflow tract anatomy will require early surgical intervention. Re-intervention rates in these patients are high due to homograft degeneration. Until recently, surgery was the only treatment option for right ventricular outflow tract dysfuncti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: D.G. Buys, S.C. Brown
Formato: article
Lenguaje:EN
Publicado: South African Heart Association 2017
Materias:
Acceso en línea:https://doaj.org/article/8201b85255944a76ab85506d36a776be
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Congenital heart lesions with abnormal right ventricular outflow tract anatomy will require early surgical intervention. Re-intervention rates in these patients are high due to homograft degeneration. Until recently, surgery was the only treatment option for right ventricular outflow tract dysfunction. Percutaneous pulmonary valve implantation has been introduced as a new therapeutic alternative to prolong conduit life span and to reduce surgical re-intervention rates. Short- and mid-term results have been favourable and showed that it is a safe and effective therapy. These are reviewed with emphasis on the Melody valve.